Answers are grounded in this paper and cite their sources.
Following intravenous administration of physostigmine salicylate for tricyclic antidepressant poisoning in 21 patients, convulsions occurred in two patients, and severe cholinergic manifestations occurred in two others. Because of these untoward effects and the very short duration of its beneficial action, it is very doubtful that physostigmine has any place in the routine management of tricyclic antidepressant poisoning.
No takes yet. Share an insight, caveat, or question.
R. W. Newton (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: